Urology practitioners need to be proactive in the evaluation and management of bone health in our prostate cancer patients on ADT, metastatic prostate cancer, and hypogonadism. A review of the pathophysiology of osteoporosis relating to ADT, hypogonadism and bone metastastes, national guidelines are discussed, appropriate screening with DXA scans or bone scans, interpretation of DXA scans, preventative health measures, exercise, and medications used to treat osteoporosis, osteopenia, and bone metastases are presented.
Contact hours available until 11/7/18.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Planning Committee Disclosures:
• Valre Welch, MSN, RN, CPNP - Consultant: Hollister Clinical Advisory Board
• Gina Powley, MSN, ANP-BC - Speakers Bureau: Astellas and Medivation
Speaker Disclosures:
• Leanne Schimke, MSN, FNP-C, CRNP, CUNP - Speakers Bureau: Bayer Xofigo
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.
Learning Outcome:
At the conclusion of this activity, the learner will be able to identify and treat those men who are at risk for osteoporosis.